Navigating the cardiovascular seas after allogeneic stem cell transplantation: charting a course for prevention - Takeaways - MDSpire

Navigating the cardiovascular seas after allogeneic stem cell transplantation: charting a course for prevention

  • By

  • Raul Cordoba

  • Queralt Salas

  • January 28, 2026

  • 0 min

Share

  • 1

    Allogeneic stem cell transplantation (alloHSCT) significantly increases the risk of cardiovascular complications in recipients.

  • 2

    Sibilia et al. found that 30% of alloHSCT patients experienced cardiotoxicity within a median follow-up of 4 years.

  • 3

    Itzhaki et al. demonstrated that the PREVENT ASCVD model is effective for predicting cardiovascular risk in alloHSCT survivors.

  • 4

    There is a critical need for improved heart failure risk prediction models due to the high incidence of heart failure post-alloHSCT.

  • 5

    Future research should validate findings in larger cohorts and explore targeted prevention strategies for cardiovascular complications.

Original Source(s)

Navigating the cardiovascular seas after allogeneic stem cell transplantation: charting a course for prevention

  • by Raul Cordoba, Queralt Salas

  • January 28, 2026

Related Content

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial

Frailty-Based Remote Monitoring in Older Adults With Heart Failure: Conceptual Framework for Adaptive Digital Health Strategies

Independent prognostic value of the triglyceride–glucose index and its incremental predictive contribution beyond traditional risk markers in acute heart failure: a retrospective cohort study